Kiora Pharma Stock Price, News & Analysis
Company Description
Kiora Pharma (OTC Link: KPHMW) is a publicly traded company.
On a trailing twelve-month basis, Kiora Pharma reported revenue of $0 with net income of -$11K and diluted earnings per share of $-2.64.
This page provides a comprehensive overview of KPHMW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
KPHMW Rankings
Latest News
SEC Filings
Kiora Pharma has filed 10 recent SEC filings, including 4 Form SCHEDULE 13G/A, 2 Form S-3, 2 Form SCHEDULE 13G, 2 Form 8-K. The most recent filing was submitted on May 18, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KPHMW SEC filings →
Financial Highlights
operating income reached -$12.8M, and net income was -$11K. Diluted earnings per share stood at $-2.64. The company generated -$10.0M in operating cash flow. With a current ratio of 5.99, the balance sheet reflects a strong liquidity position.